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Abstract Defective primary ciliogenesis or cilium stability forms the basis of human ciliopathies,
including Joubert syndrome (JS), with defective cerebellar vermis development. We performed a high-
content genome-wide small interfering RNA (siRNA) screen to identify genes regulating ciliogenesis as
candidates for JS. We analyzed results with a supervised-learning approach, using SYSCILIA gold
standard, Cildb3.0, a centriole siRNA screen and the GTex project, identifying 591 likely candidates.
Intersection of this data with whole exome results from 145 individuals with unexplained JS identified
six families with predominantly compound heterozygous mutations in KIAA0586. A c.428del base
deletion in 0.1% of the general population was found in trans with a second mutation in an additional
set of 9 of 163 unexplained JS patients. KIAA0586 is an orthologue of chick Talpid3, required for
ciliogenesis and Sonic hedgehog signaling. Our results uncover a relatively high frequency cause for JS
and contribute a list of candidates for future gene discoveries in ciliopathies.
DOI: 10.7554/eLife.06602.001
eLife digest Joubert syndrome is a rare disorder that affects the brain and causes physical,
mental, and sometimes visual impairments. In individuals with this condition, two parts of the brain
called the cerebellar vermis and the brainstem do not develop properly. This is thought to be due to
defects in the development and maintenance of tiny hair-like structures called cilia, which are found
on the surface of cells.
Currently, mutations in 25 different genes are known to be able to cause Joubert syndrome.
However, these mutations only account for around 50% of the cases that have been studied, and the
‘unexplained’ cases suggest that mutations in other genes may also cause the disease.
Here, Roosing et al. used a technique called a ‘genome-wide siRNA screen’ to identify other
genes regulating the formation of cilia that might also be connected with Joubert syndrome. This
approach identified almost 600 candidate genes. The data from the screen were combined with gene
sequence data from 145 individuals with unexplained Joubert syndrome. Roosing et al. found that
individuals with Joubert syndrome from 15 different families had mutations in a gene called
KIAA0586. In chickens and mice, this gene—known as Talpid3—is required for the formation of cilia.
Roosing et al.’s findings reveal a new gene that is involved in Joubert syndrome and also provides
a list of candidate genes for future studies of other conditions caused by defects in the formation of
cilia. The next challenges are to find out what causes the remaining unexplained cases of the disease
and to understand what roles the genes identified in this study play in cilia.
DOI: 10.7554/eLife.06602.002
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Introduction
A range of disorders from isolated organ defects like blindness or nephronophthisis to multi-system
disorders like Joubert (JS), Bardet–Biedl, or Meckel–Gruber syndromes are correlated with mutations
in genes involved in formation or stability of the primary cilium (Goetz and Anderson, 2010; Waters
and Beales, 2011; Brown and Witman, 2014). JS is characterized by a distinctive midbrain–hindbrain
malformation, named the ‘molar tooth sign’ on brain magnetic resonance imaging, and clinically by
developmental delay, oculomotor apraxia and hypotonia. Currently, 25 genes are known to cause JS
when mutated in a bi-allelic or X-linked fashion (Akizu et al., 2014; Beck et al., 2014; Romani et al.,
2014). Most of the encoded proteins from these genes localize to the primary cilium or are involved in
ciliary-related transport and commonly result in defective ciliation in patient cells or in animal models
(Singla et al., 2010; Valente et al., 2013; Akizu et al., 2014). Importantly, still about half of cases
studied by exome sequencing remain genetically unsolved, suggesting many as yet unidentified
causes (Akizu et al., 2014).
Although traditional homozygosity mapping or exome sequencing has uncovered many genes for
these conditions, these approaches may fall short for genes under strong selective pressure or for
genes in which homozygous loss-of-function mutations are embryonic lethal. One approach to identify
new human disease genes is to intersect cell biological, genomic, or protein interaction data in order
to prioritize candidates for closer inspection. For instance, a protein interaction network derived
from genes previously implicated in the ciliopathies identified mutations in TCTN2 in JS patients
(Sang et al., 2011). Similarly, comparing gene content from species with and without cilia led to
identification of BBS5 in Bardet–Biedl syndrome patients (Li et al., 2004).
There have been few systematic approaches towards characterization of genes required for
ciliogenesis. A small interfering RNA (siRNA) screen of 7784 pharmacologically relevant genes
identified 36 positive and 13 negative ciliogenesis modulators (Kim et al., 2010), and a study of 815
‘kinome’ genes identified 9 candidates affecting ciliary signaling (Evangelista et al., 2008), but
neither study was genome-wide. A recent phylogenetic co-occurrence study identified 206 core cilia
components (Dey et al., 2015), but no link with disease was shown. Given defective ciliogenesis in
patient cells, we reasoned that a genome-wide siRNA screen to identify ciliogenesis factors could help
prioritize candidates, especially for families in which traditional exome-sequencing approaches have
not yet yielded a cause.
One of the caveats of screening for such genes is that ciliogenesis is intimately linked with mitosis
(Kim et al., 2011; Plotnikova et al., 2012), and thus, genes arresting the cell cycle prior to
ciliogenesis might be inadvertently flagged as affecting ciliogenesis. Recent live cell cycle imaging
markers make it possible to separately flag cell cycle genes, which could greatly increase the
specificity of ciliogenesis screens.
Our focus was to identify novel genes involved in JS, by applying a functional genomics approach,
then intersecting the data with a cohort of unsolved exome-sequencing results from JS patients. We
conducted a high-throughput genome-wide siRNA knockdown study for 18,045 human genes in
a ‘two-color’ cell line engineered to report ciliary-localized EGFP and cells in G2/M phase using
mCherry-tagged Geminin. A range of cellular features were measured for all genes, and compared with
a positive and negative training set, resulting in a prioritized list of 591 ciliary candidates. This list was
used to prioritize variants from 145 JS patients on whom exome sequencing had not revealed a cause.
We identified deleterious variants KIAA0586 in a total of 15 families. This gene was previously missed
by exome sequencing, most likely due to a high-carrier frequency of a common allele in a predominantly
compound heterozygous inheritance, thus, precluding a homozygosity mapping approach or filtering
focused on rare variants. Together with a lethal phenotype in other species (Bangs et al., 2011), the
data suggest that humans may have redundancy or compensation that preclude lethality or that the
KIAA0586 mutations only partially inactivate protein function. The results also support a cell-based
screening approach to complement exome sequencing in human mutation identification.
Results
Generation of SEMG cell line
The ciliated stable cell line, human telomerase reverse transcriptase (hTERT)-retinal pigment epithelial
1 (RPE1) Smo-EGFP (Kim et al., 2010), in which Smoothened–tagged EGFP is stably integrated in the
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polarized human RPE1 cells, reliably reports a single primary cilium upon serum withdrawal in 60–80%
of cells. This line was stably transfected with mCherry-tagged Geminin (Sakaue-Sawano et al., 2008),
a nuclear marker for S/G2/M cell cycle phases, to produce the Smo-EGFP-mCherry-Geminin/hTERT-
RPE1 (SEMG) line, enabling differential analysis of ciliogenesis as a function of the cell cycle. Cells
lacking a cilium (i.e., absent ciliary-localized EGFP fluorescence) were divided into those in G2/M
phase (should normally not display a cilium) and those in G0/G1 (most should display a cilium;
Figure 1A,B). The incorporation of mCherry-Geminin increased the specificity of the screen by
filtering siRNAs leading to cell cycle arrest as the primary reason for absent cilia.
Using this approach, we first optimized seeding density, serum withdrawal conditions, and imaging
parameters using a siRNA positive control for cilia (i.e., no known effect on the cell cycle but blocking
ciliogenesis) of KIF3A, and for cell cycle (i.e., no direct effect on ciliogenesis but traps cells in G2/M
phase of the cell cycle or the effect described above) of ACTR3 and CRNKL1, and verified reporters
were robust (Figure 1C).
Cell-based screen and validation of whole-genome siRNA data set
We conducted a high-throughput siRNA knockdown study for 18,045 genes of the human genome
performed in duplicate, using 4–5 unique pooled siRNAs per gene. After siRNA transfection, ciliation
was induced by serum starvation, then fixed and imaged in 384-well plates in three channels
(see ‘Materials and methods’). 18 non-overlapping cellular features reflecting nuclear, cytoplasm and
ciliary state, combined into 31 parameters (Supplementary file 1), yielding 559,395 values across the
screen (Supplementary file 2).
Development of the CILIOGENESIS data set
The rationale of our whole-genome siRNA screen with SEMG cells was to obtain data allowing for
identification of genes as potential candidates as a cause of JS by using a supervised learning
approach. We trained a Random Forest classifier using known ‘ciliary genes’ as a positive training set,
derived from the SYSCILIA consortium gold standard (SCGSv1) composed of 303 confirmed factors
(van Dam et al., 2013). The negative set incorporated genes not involved in any currently known
ciliary processes and included 5445 genes annotated in the human metabolome database (HMDB 3.0)
(Wishart et al., 2013), as well as a manually curated set of 666 housekeeping genes. To ensure
accurate annotation of gene sets used in the classifier training, all genes were cross checked with
Cildb V3.0, a database of ‘ciliary genes’ (i.e., genes with presumed ciliary function) based on high-
throughput studies across multiple species (Arnaiz et al., 2009, 2014). Based on this resource, we
removed genes with conflicting annotation from both the positive and negative sets, leaving a final list
of high-confidence positive (n = 244) and negative (n = 1802) cilia candidates.
We evaluate the performance of the trained classifier on cilia candidates from the SCGSv1, which
included an additional list of 419 ciliary gene candidates, not used to train the classifier. Of these, 21%
were flagged by the classifier as likely ciliary. Furthermore, there was significant enrichment compared
to the negative set of metabolomics and housekeeping genes not included in the classifier training set
(p < 1.08 × 10−25, one-tailed Wilcoxon rank sum).
Next, classifier performance was evaluated by examination of the area under the receiver
operating characteristic-curve (AUC). Along with both replicates of the whole-genome siRNA screen,
we included data from a siRNA screen designed to identify regulators of centriole biogenesis
(Balestra et al., 2013) and gene expression signatures derived from the Genotype-Tissue expression
(GTEx) tissue specific RNAseq data (Figure 1D,E, Figure 1—figure supplement 1, Figure 1—figure
supplement 2) (GTEx Consortium, 2013). Of the 16,431 genes screened in all three data sets,
the classifier predicted 1299 genes (7.9%) as likely ciliary, which we call the CILIOGENESIS
database (Ciliary List of Candidate Genes using an siRNA Strategy, Supplementary file 3A,B). We
also define a high-confidence subset of 591 ciliary genes by controlling for the false discovery rate
(FDR < 0.1), which is estimated based on the classifier score and training set labels calculated.
This high-confidence list includes many established ciliopathy genes such as TTC26, CEP83, IFT88,
and SPATA7, as well as 14 of 25 known JS causative genes. Of the remaining JS causative genes, two
others were included when FDR scores were loosened to 0.21 and 0.25. The remaining eight other JS
causative genes (32%) were all found well above the genome-wide median classifier score (lowest
ranked gene observed at 58th percentile), but not in the top list, possibly as a result of their activity
Roosing et al. eLife 2015;4:e06602. DOI: 10.7554/eLife.06602 4 of 19
Research article Developmental biology and stem cells | Human biology and medicine
Figure 1. Schematic representation, validation and enrichment of genome-wide siRNA cell screen for machine learning approach. (A) High-content small
interfering RNA (siRNA) cell-based screen using reverse transfection of the library in media containing serum for 72 hr, followed by 24 hr serum starvation,
fixation and DAPI staining. Subsequent fluorescent imaging and algorithmic analysis performed for all pooled siRNAs. To assess ciliary candidates for the
positive training, we used SYSCILIA gold standard (SCGSv1) and for the negative training the human metabolome database (HMDB 3.0) as well as
a manually curated housekeeping gene data set. FDR, false discovery rate. (B) Segmentation algorithm for cytoplasm and cilia detection: (1) detected
nuclei from DAPI channel, (2) nuclear automated segmentation, (3) cell outline automated using cytoplasm_detection_D of the program Acapella, and
(4) cilia automated detection and segmentation. Images have been modified for illustration purposes. Scale bar: 10 μm. (C) Representative images of
serum-starved SEMG cells without siRNA showing basal ciliation (small green rods in EGFP channel). Red (mCherry) marks cells in S/G2/M phase of
the cycle, green (EGFP) marks cilia, blue (DAPI) marks nuclei. siRNAs used as positive controls: KIF3A interferes with ciliation but not cell cycle. ACTR3
shows increased length of cilia (Kim et al., 2010). CRNKL1 implicated in cell cycle progression (Zhang et al., 1991) and showed increased mCherry nuclei
and reduced ciliation. Scale bar: 10 μm. (D) Receiver operating characteristic (ROC) for the classifier, which used features from three data sources.
Dashed line: theoretical random classifier. (E) Precision-recall curve for the final classifier. (F) Median value (red center bar) and interquartile ranges (blue
box) box plot of the classifier scores for the corresponding number of supporting number of evidences (NOEs) in Cildb and the genes used as negative
and positive training examples. The indicated contrasts were found significant(*) with a highest value of p < 1.03 × 10−4 (one-tailed Wilcoxon’s Rank sum
test). (G) Same as (F), limited to the NOEs from humans only. The indicated contrasts were found significant(*) with a highest value of p < 1.43 × 10−10 (one-
tailed Wilcoxon’s Rank sum test). See Figure 1—figure supplement 1, 2 for the prediction score on the gold standard and candidates as well as the
visible improvement of the ROC curve and precision–recall curve.
DOI: 10.7554/eLife.06602.003
The following figure supplements are available for figure 1:
Figure supplement 1. Prediction score on Gold standard and Gold standard candidates.
DOI: 10.7554/eLife.06602.004
Figure supplement 2. Visible improvement of ROC curve and precision-recall curve.
DOI: 10.7554/eLife.06602.005
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outside the cilium. Of the high-confidence genes included in the CILIOGENESIS database, 26% were
previously included in the SCGCv1, yielding 438 novel candidates.
Cildb is a multispecies knowledge base constructed through integration of high-throughput
screens aimed at identifying ciliary or ciliary-related genes. Cildb outputs two integers for each gene
in the knowledge base, referring to independent experimental ‘number of evidences’ (NOEs, i.e.,
publications) indicating ciliary association, with one for NOE in human studies and one for NOE in ‘any
species’. We compared gene-specific classifier score (excluding any genes used in training) with the
Cildb NOE output. Significant positive trends were observed when comparing to increasing NOE in
both the multi-species and human-only sets (Jonckheere–Terpstra test, see methods, p < 3.04 × 10−29
and p < 6.50 × 10−42, Figure 1F,G). Moreover, we also observed a significant difference when
comparing scores in any of the NOE bins to the zero NOE bin in both the multi-species and human
sets (p < 1.03 × 10−4 and p < 1.43 × 10−10, respectively, one-tailed Wilcoxon rank sum).
Enrichment analysis of the CILIOGENESIS data set
To identify possible candidates for ciliopathies, we performed a gene ontology (GO)-term enrichment
analysis on the high-confidence gene list, with functional annotation clustering using DAVID (Huang
da et al., 2009a; Huang da et al., 2009b). We used a GO-enrichment cutoff of FDR <0.05
(Benjamini–Hocheberg test). To ascertain the novelty of genes included in the CILIOGENESIS data
set, we excluded SCGSv1 genes used in the training, leaving 1,177 genes. GO enrichment resulted in
several significant terms including non-membrane bound organelle, microtubule cytoskeleton/
centrosome, spermatogenesis, and microtubule cytoskeleton organization demonstrating an
agreement with previous annotations for cilia associations (Supplementary file 3C). The involvement
of ciliary processes in the CILIOGENESIS data set was supported by MsigDB analysis showing gene
enrichment among others for the recruitment of mitotic centrosome proteins and complexes,
microtubule/cytoskeleton and centrosome (Supplementary file 3D,E) (Subramanian et al., 2005).
Enrichment validation suggested that the CILIOGENESIS data set may be enriched for ciliopathy
disease genes.
Intersection of CILIOGENESIS with unsolved JS cases highlights
KIAA0586
Previous whole-exome sequencing in 287 cases of JS left ∼50% without a genetic explanation
(Akizu et al., 2014), suggesting additional causes remain to be identified. Of these, 75% displayed
parental consanguinity, suggesting that causative variants might be homozygous. In about half of the
remaining cases, sequencing on at least one parent was available, enabling phasing of identified
alleles. From these 145 individuals, we tabulated 5485 variants containing 2348 homozygous variants
and 3137 potentially compounds heterozygous variant pairs. We prioritized variants occurring within
the coding region and canonical splice sites of any of the 591 CILIOGENESIS genes, and identified
179 variants including 106 homozygous and 73 potentially compound heterozygous variant pairs, or
a 96.7% reduction in variants to be considered. Collectively, variants were identified in 112 of the 591
CILIOGENESIS genes, respectively. The only gene with more than two families displaying variants was
KIAA0586, prompting further analysis.
KIAA0586 (i.e., the orthologue of chicken and mouse Talpid3) is composed of 34 exons with at
least six major transcripts (Figure 2A). From these 145 sequenced probands (written informed
consent provided), there were four displaying putative compound heterozygous and two displaying
homozygous potentially deleterious variants. Interestingly, in each of the four compound
heterozygous probands, there was a shared frameshift mutation, (chr14:58899157del; c.428del, p.
Arg143Lysfs*4), which we refer to as M1 (mutation 1). Each of the four carried a single additional
potentially deleterious variant, including mutations in a canonical acceptor splice site (chr14:
58915212G>A; c.1120+1G>A, p.Thr323Hisfs*3; M2), a canonical donor splice site (chr14:
58923419G>C; c.1413-1G>C; p.Phe472Alafs*5; M3), and a missense affecting the start codon of
two transcripts (chr14:58896138T>C; c.293T>C; p.Met98Thr; M4; T1; or c.2T>C; p.Met1?; T4-T5,
where T refers to transcript number). Implementing an algorithm to identify copy number variants
from exome-sequencing data (Fromer et al., 2012), we additionally identified a deletion of 15.5
kilobases (Kb) spanning exon 10–17 (chr14:?_58923420_58938997_?del; c.1413-?_2793+?del; p.?;
M5) in one patient. These mutations were all confirmed with Sanger sequencing or quantitative PCR,
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Figure 2. Pedigrees and schematic representation of KIAA0586. (A) Genomic structure and mRNA transcripts of KIAA0586. Transcript 1 (T1): full-length
isoform with 34 exons. T2–T4 have different initiation sites, lack exon 5, and T3 lacks exon 14. T5 starts at the same position as T4 and incorporates exon 6.
The shortest transcript (T6) initiates in exon 7, lacks exon 32 and 33, and terminates using an alternative exon, which is not incorporated in the other
transcripts. Gray boxes represent alternative exons. UTR’s are represented by half-height boxes. The location of the mutations is indicated by M1–M7.
(B) Pedigrees of the Joubert syndrome (JS) families with ancestries of USA (MTI-233 and MTI-103), Mexico (MTI-165), Turkey (MTI-1944 and COR354), and
Syria (MTI-505), respectively, demonstrating the segregation of the compound heterozygous mutations in non-consanguineous families and homozygous
mutations in consanguineous families. Inferred genotype is italicized. M, mutation; T, transcript. See Figure 2—figure supplement 1 for the
chromatograms of the mutations in KIAA0586. Figure 2—figure supplement 2 shows the results of the quantitative PCR confirming the large
heterozygous mutation in MTI-1944.
DOI: 10.7554/eLife.06602.006
The following figure supplements are available for figure 2:
Figure 2. continued on next page
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and all segregated according a strict recessive mode of inheritance in all available family members
(Figure 2B, Figure 2—figure supplement 1, Figure 2—figure supplement 2). We conclude that
compound heterozygous variants in KIAA0586 contribute to JS. Each patient carrying the M1
mutation had a demonstrable second mutation on the other allele, suggesting a recessive mode of
inheritance.
Two consanguineous families each showed a homozygous mutation in KIAA0586. One was
predicted to alter splicing in a constitutively incorporated exon (c.2414-1G>C; p.?; M6). The other was
a single base-pair deletion (c.74del; p.Lys25Argfs*6; M7), in an exon incorporated into only three of
the six annotated transcripts, all of which are ubiquitously expressed. We conclude that homozygous
mutations in KIAA0586 can also contribute to JS.
The common frameshift variant M1 was identified in all four families with compound heterozygous
mutations. Evaluation of M1 in the Exome Variant Server (NHLBI GO Exome Sequencing Project (ESP),
Seattle, WA, URL: http://evs.gs.washington.edu/EVS/ [May, 2015]) identified in 25/7,757 European
American alleles and 3/3511 African American alleles, all in a heterozygous state, presumably all in
healthy individuals. Exome Aggregation Consortium (ExAC, Cambridge, MA, URL: http://exac.
broadinstitute.org [May, 2015]) showed an overall frequency of 244/120,680 M1 alleles. Combining
these with the 1000 Genomes data suggests an allele frequency of 0.0036 in the general population.
We conclude that M1 is a relatively common allele in the general population, found in about 1/300
individuals. The M1 variant was found in individual of varying ancestry, but we cannot exclude
a common founder mutation.
Evaluation of KIAA0586 as a candidate gene in other JS cohorts
We speculated that M1 was likely to represent a common mutation among JS patients. Thus, we
screened an additional cohort of 163 classical JS patients with a proven ‘molar tooth sign’ collected
primarily from Mediterranean regions. The M1 allele was surprisingly identified in 17 of 326 alleles
(5.21%), of which one was homozygous (Figure 3 individual NG2872). Ethnically matched
Mediterranean controls showed 2/536 M1 alleles (0.37%, p < 0.0001, odds ratio 13.51). In the
remaining 15 individuals, we attempted comprehensive Sanger sequencing of the entire KIAA0586
transcript, eventually identifying a pathogenic variant in eight individuals (57%), all leading to
predicted splice, stop or frameshift changes, again consistent with recessive inheritance. In the other
seven JS patients, a second mutation was not yet identified (Table 1, Table 1—source data 1).
Although it is possible that one or more of these individuals carries M1 by chance, it is most likely that
a second mutation exists, not yet uncovered.
To evaluate the effect of predicted splicing mutations in KIAA0586, we generated mRNA from
cultured fibroblasts of an affected and unaffected member of family MTI-233 and MTI-103, displaying
an M1 compounded with a splice mutation (M2 or M3, respectively). Sanger sequencing of poly-A
primed mRNA showed that the mutation M2 led to the skipping of exon 9 and mutation M3 led to
utilization of a cryptic splice acceptor located 16 bp downstream (i.e., 3′), resulting in a frameshifted
transcript (Figure 2—figure supplement 1B,C), suggesting partial or complete loss-of-function.
Loss-of-function mutations in Talpid3 result in a short-rib polydactyly-like phenotype in chicken and
mouse, with a vascular defect and early lethality, all attributable due to defective ciliogenesis (Bangs
et al., 2011; Davey et al., 2014). Our patients presented classical features of JS including the MTI of
varying severity (Figure 3, Figure 3—figure supplement 1), without lethality or demonstrable
excessive fetal wasting in affected families. Most cases displayed hypotonia, ataxia, developmental
delay, and intellectual disability without skeletal or limb malformations. Breathing abnormalities,
seizures, macrocephaly, and ophthalmological defects were found in a subset of the cases
(Supplementary file 4A). The affected child of MTI-165 passed away at the age of 18 months from
Figure 2. Continued
Figure supplement 1. Chromatograms of mutations in the KIAA0586 gene.
DOI: 10.7554/eLife.06602.007
Figure supplement 2. Quantitative PCR confirmed heterozygous mutation in MTI-1944.
DOI: 10.7554/eLife.06602.008
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apnea, and no imaging was available. The results support the involvement of KIAA0586 in the
pathogenesis of JS.
Mutated KIAA0586 results in absence of detectable protein in patient
cells
RT-PCR analysis with primers spanning various transcripts showed ubiquitous KIAA0586 expression in
various tissues (Figure 4—figure supplement 1A). To determine the effect of mutations on KIAA0586
protein level, we analyzed patient fibroblasts of family MTI-103 and MTI-233 by Western analysis using
a KIAA0586-specific antibody (Kobayashi et al., 2014). The level of KIAA0586 protein in patient
samples was below detection, whereas both carriers showed reduced but detectable expression
compared with control (Figure 4). In human RPE1 cells transfected with KIAA0586 siRNA, we
documented reduced protein levels, supporting antibody specificity.
Figure 3. MRI scans from patients with KIAA0586 mutations. Magnetic resonance imaging (MRI) in a healthy individual and patients with KIAA0586
mutations showing thickened and mal-oriented superior cerebellar peduncle (upper, red ‘arrowheads’), deepened interpeduncular fossa and constituting
the ‘molar tooth sign’ (red circle). In COR-354-2-3, the molar tooth sign was very mild, possibly due to suboptimal image averaging. Figure 3—figure
supplement 1 shows the imaging phenotype of affected JS individual MTI-1944-2-1.
DOI: 10.7554/eLife.06602.009
The following figure supplement is available for figure 3:
Figure supplement 1. Imaging phenotype of affected JS individual MTI-1944-2-1 with KIAA0586 mutations.
DOI: 10.7554/eLife.06602.010
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Discussion
Here, we identify KIAA0586 mutations in JS using a combination of cell-based screening and exome
sequencing. By training of a classifier to prioritize ciliary candidate genes based upon shared loss-of-
function phenotypes, we generated a data set we called CILIOGENESIS consisting of 591 prioritized
genes. Intersecting these genes with WES data of genetically unexplained JS individuals led to the
discovery of mutations in KIAA0586, which we found to be a relatively common cause (i.e., about 5%)
in unsolved JS cases. In patient cells, there was undetectable KIAA0586 protein supporting its role in
JS pathogenesis. It remains to be determined whether mutations in KIAA0586 can lead to other
ciliopathies like Meckel–Gruber syndrome or nephronophthisis, which are often allelic to JS.
Our siRNA screen incorporated several improvements over previously published but similar screens.
As the first genome-wide siRNA high-content screen for defective ciliogenesis, we evaluated nearly
each of the annotated human genes with at least four siRNAs per gene. Second, we incorporated
a specific cell phase marker, mCherry-Geminin, to exclude false-positives that might result from cell
cycle defects. Third, we incorporated a machine learning approach with positive and negative training
sets, which enhanced the predictability of measured cellular features as they relate to ciliogenesis.
It is noteworthy that including features in the classifier from multiple sources, while improving
performance of the classifier, caused a reduction from 18,045 targets to 16,431 targets due to
missing values (n = 798 targets lost by the biogenesis siRNA screen; n = 786 targets lost by the GTEx
RNAseq data). It is possible that some ciliary factors were not correctly classified as such due to
incomplete data in these comparative screens. Inevitability, our machine learning approach will be
biased towards currently known ciliary factors, and as more knowledge is gained, the power of such
approaches will improve. Even by combining the CILIOGENESIS data set with exomes from 145
Table 1. All alleles identified in KIAA0586 causative for Joubert syndrome
Allele 1 (based on T1) Allele 2 (based on T1)
Patient ID Genotype Genomic DNA Protein Genomic DNA Protein
MTI-233 M1/M2 g.58899157del c.428del p.Arg143Lysfs*4 g.58915212G>A c.1120+1G>A p.Thr323Hisfs*3
MTI-103 M1/M3 g.58899157del c.428del p.Arg143Lysfs*4 g.58923419G>C c.1413-1G>C p.Arg472Serfs*2
MTI-165 M1/M4 g.58899157del c.428del p.Arg143Lysfs*4 g.58896138T>C c.2T>C
(based on T4-T5)
p.Met1?
(based on T4-T5)
MTI-1944 M1/M5 g.58899157del c.428del p.Arg143Lysfs*4 g.?_58923420_
58938997_?del
c.1413-?_2793+?del p.?
MTI-505 M6/M6 g.58934452G>C c.2414-1G>C p.? g.58934452G>C c.2414-1G>C p.?
COR354 M7/M7 g.58895020del c.74del p.Lys25Argfs*6 g.58895020del c.74del p.Lys25Argfs*6
Mediterranean cohort analysis
NG2872 M1/M1 g.58899157del c.428del p.Arg143Lysfs*4 g.58899157del c.428del p.Arg143Lysfs*4
NG4158 M1/M8 g.58899157del c.428del p.Arg143Lysfs*4 g.58909503C>T c.649C>T p.Gln217*
NG2326 M1/M9 g.58899157del c.428del p.Arg143Lysfs*4 g.58910790_58910791del c.863_864del p.Gln288Argfs*7
NG1776 M1/M9 g.58899157del c.428del p.Arg143Lysfs*4 g.58910790_58910791del c.863_864del p.Gln288Argfs*7
NG3928 M1/M10 g.58899157del c.428del p.Arg143Lysfs*4 g.58915097C>T c.1006C>T p.Gln336*
NG2458 M1/M11 g.58899157del c.428del p.Arg143Lysfs*4 g.58924613_
58924616delinsAAA
c.1658_1661delinsAAA p.Val553Glufs*79
NG2286 M1/M12 g.58899157del c.428del p.Arg143Lysfs*4 g.58925263G>A c.1815G>A p.= / p.?
NG1485 M1/M13 g.58899157del c.428del p.Arg143Lysfs*4 g.58927869C>T c.2209C>T p.Arg737*
NG3758 M1/M14 g.58899157del c.428del p.Arg143Lysfs*4 g.58953883del c.3462del p.Gly1155Glufs*40
M; mutation; T; transcript. Table 1—Source data 1 shows chromatograms belonging to the identified mutations in the Mediterranean cohort.
DOI: 10.7554/eLife.06602.011
Source data 1. Chromatograms of mutations in the KIAA0586 gene identified in the additional cohort of Mediterranean individuals with Joubert
syndrome.
DOI: 10.7554/eLife.06602.012
Roosing et al. eLife 2015;4:e06602. DOI: 10.7554/eLife.06602 10 of 19
Research article Developmental biology and stem cells | Human biology and medicine
individuals identified only a single recurrently
mutated gene, leaving the majority of families
still unexplained (Akizu et al., 2014). This
observation leads us to postulate that there are
probably few commonly mutated genes remain-
ing to be discovered in JS.
Our siRNA screen is probably underpowered
to detect JS genes primarily involved in effects like
signaling through Sonic hedgehog or Wnt path-
ways. Gene set enrichment analysis of the true
positive SCGCv1 genes (SCGCv1 genes ranked
within the CILIOGENESIS data set genes) with
MsigDB (Subramanian et al., 2005) showed
enrichment for cytoskeletal genes as expected
(Supplementary file 3F), whereas analysis on false
negative genes (SCGCv1 genes ranked outside
the CILIOGENESIS data set genes) showed
significant enrichment for photoreceptor cell
maintenance, sensory perception, Sonic hedge-
hog pathway, and post-chaperonin tubulin folding
pathway (Supplementary file 3G). This suggests
that the CILIOGENESIS data set may be enriched
for genes involved in the process of ciliogenesis,
whereas genes involved in signaling functions are
less likely to be detected. Moreover, this is in agreement with analysis of candidate targets involved in
Hedgehog signaling from screens described in literature for which we observe no enrichment in the
CILIOGENESIS data set (Supplementary file 3A,B) (Evangelista et al., 2008; Jacob et al., 2011). It is
possible that extending the CILIOGENESIS data set to include factors regulating the ciliary
responsiveness to Hedgehog or Wnt activators or suppressors could further improve sensitivity.
Talpid3 participates in the earliest stages of ciliation, including centriolar satellite dispersal and
plasma membrane docking of the basal body (Davey et al., 2014; Kobayashi et al., 2014). Although
Cep290 and Talpid3 share some similarities in ciliary phenotypes, there are distinct cellular functions
(Kobayashi et al., 2014). Talpid3 forms a ring-like structure at the distal end of both centrioles and is
involved in the initiation of ciliary vesicle formation and docking, whereas Cep290 functions in the
maturation of these vesicles. Moreover, Talpid3 is localized asymmetrically in mother and daughter
centrioles and is crucial for limiting the levels of Cep120 at the mother centriole (Wu et al., 2014). In
Talpid3 mutant mouse embryos, centrosomes fail to dock at the plasma membrane and cilia are
absent in various tissues (Yin et al., 2009), associated with embryonic lethality.
KIAA0586 might have been identified as mutated in JS even without the CILIOGENESIS data set,
but was missed, probably for several reasons. First, the difference in names of the human and mouse
genes made it difficult to link the two in automated curation of exome variants. Second, the majority
of mutations were compound heterozygous, precluding homozygosity mapping analysis. Third, the
higher frequency of the common allele M1 in the general population reduced its priority as
a candidate, since the rarest alleles are prioritized over common alleles. Thus, we foresee the
CILIOGENESIS data set and other orthogonal approaches as potentially beneficial in gene discovery.
The 1/300 calculated carrier frequency of M1 in the population is comparable to the deep intronic
founder mutation of ∼1/500 (c.2991+1655A>G) in CEP290 as the most common cause of Leber
congenital amaurosis in Caucasians, but less than the ∼1/100 in TMEM216 as a cause for JS in the
Ashkenazi population (den Hollander et al., 2006; Valente et al., 2010). Of the 15 patients with
heterozygous M1 in the Mediterranean cohort, we identified a second truncating allele in KIAA0586 in
57%, and the remaining are still under investigation for non-coding or deletion mutations. We
screened a cohort of 800 individuals with nephronophthisis with retinopathy, and found four carrying
the M1 mutation, close to the predicted 0.0036 expected carrier frequency and no convincing second
mutations were documented in this cohort. Thus, it remains to be determined if KIAA0586 mutations
are associated with other ciliopathy phenotypes or can lead to embryonic lethality.
Figure 4. Absent KIAA0586 protein in patient
fibroblasts. Immunoblot analysis of KIAA0586 in fibro-
blasts from family MTI-103 and MTI-233. Lysates from
RPE1 cells transfected with scrambled or KIAA0586
siRNA were used as control. M, unaffected carrier
(mother); A, affected child. RPE1, retinal pigment
epithelial-1 cell line. Figure 4—figure supplement 1A
represents an expression analysis of the KIAA0586 gene.
DOI: 10.7554/eLife.06602.013
The following figure supplement is available for figure 4:
Figure supplement 1. Expression analysis of the
KIAA0586 gene.
DOI: 10.7554/eLife.06602.014
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Because the mutations affect only exons incorporated in a subset of transcripts or affect splicing
(which can be leaky) and because of embryonic lethality in mouse and chick with homozygous null
mutations, we speculate that humans surviving with KIAA0586 mutations may retain partial function.
The M4 allele was predicted to cause loss of the initiator methionine in transcript T4 and T5,
potentially leaving other transcripts intact. M4 was encountered in public sequence databases ESP
and ExAC with a frequency of 0.002 (322/132,340 alleles), including three homozygous cases with
unknown health status. The M7 allele affects three of six transcripts, while no protein was detected on
Western blot from patient cells. It will be important to model these alleles or check for
complementation of two null alleles with the patient alleles.
Materials and methods
Cell culture
hTERT-transformed RPE1 cells were cultured in DMEM/F12 medium supplemented with 10% fetal bovine
serum (FBS), under standard conditions (37˚C, 5% CO2). Plasmid DNAs harboring mouse Smo-EGFP and
mCherry-Geminin (1–110aa) fusion genes were transfected to hTERT-RPE1 cells and the stable cell line;
Smo-EGFP-mCherry-Geminin/hTERT-RPE1 (SEMG) was established by G418 selection. To induce
ciliogenesis, the cells were serum starved on serum-free DMEM/F12 media for 24–48 hr prior to fixation.
Whole-genome siRNA library screen
Primary screen
An arrayed library containing pooled siRNAs targeting 18,045 human genes (Dharmacon, Lafayette,
CO) was screened in duplicate. Assay plates (384-well plate with optical bottom; Greiner Bio-One,
Monroe, NC) were spotted with 1 μl of 0.5 μM siRNA using the Velocity 11-Bravo Pipette with a 384 ST
head. Reverse transfection was performed using Lipofectamine RNAiMAX: final siRNA concentration
was 10 nM. SEMG cells were suspended in DMEM/F12 supplemented with 10% FBS and seeded onto
assay plates using the Matrix-Well Mate (2,000 cells in 40 μl medium for each well). Culture medium
was replaced with DMEM 24 hr after transfection using the TiterTek-MAP-C, and cells were incubated
for additional 48 hr before fixation in 4% PFA and subsequent staining with DAPI.
Imaging and image analysis
Image acquisition of the siRNA screen was performed on the Opera QEHS system (PerkinElmer,
Waltham, MA). All cells were imaged with a 20× objective in a standardized manner using the Opera
QEHS system (Perkin Elmer, Waltham, MA). The nuclei were stained with DAPI and exposed for ∼10
ms using the non-confocal light path at 365-nm excitation with an and a 450/50-nm emission filter. The
green fluorescence for expression of Smo was acquired at 488-nm excitation using the confocal
system. The expression of Geminin was measured at 561-nm laser line using the confocal system. Each
well was imaged in triplicate. Acapella 2.0 software (PerkinElmer, Waltham, MA) was used to perform
image segmentation and cytometry with similar algorithms previously described (Kim et al., 2010). 31
output parameters were obtained by an algorithm generated for segmentation of the nucleus,
cytoplasm, and primary cilium in the SEMG cells (Figure 1A–C, Supplementary file 1). The algorithm
applied for segmentation of the nucleus, cytoplasm, and primary cilium in SEMG was confirmed by the
manual imaging analysis in both serum positive and negative conditions.
Random Forest classification of cilia genes
Data generated by whole-genome siRNA high-content screen were quantile normalized across
batches to facilitate cross validation. The SYSCILIA gold standard (SCGSv1) of known ciliary
components (van Dam et al., 2013) was used as positive training examples. The SCGSv1 included
303 genes curated by the SYSCILIA consortium associated to a ciliopathy, ciliary localization, or
function in ciliogenesis (van Dam et al., 2013). An additional list which included 419 candidate
ciliopathy associated genes, which accompanied the gold standard, was used to benchmark the
performance of our classifier and was excluded from training. As non-ciliary examples, we used
two non-ciliary sets, the metabolome consisting of 5,445 genes (Wishart et al., 2013) and
a manually created list of housekeeping genes of 666 genes. To further hone the positive and
negative training sets, we use Cildb (V3.0) a comprehensive resource aggregating experimental
evidence from 15 model organisms including humans (Arnaiz et al., 2009, 2014). Genes
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appearing in the Cildb list with any evidence of involvement in ciliary related processes were
excluded (n = 9,073) from our negative training set, and in similar ways, genes in the
positive training set were removed if evidence of ciliary involved was not seen in Cildb. The
final positive training set composed of 244 genes, whereas in the negative training sets 1,802
genes remain. To prioritize candidate genes for ciliopathies, a Random Forest classifier was
trained to accurately classify positive from negative samples based on features from data
generated by our whole-genome siRNA screen, data from centriole formation from Balestra et al.,
and patterns of gene expression signatures across tissue from the GTEx project (GTEx
Consortium, 2013).
First, the classifier was trained on the first replicate data set of the whole-genome siRNA
experiment and tested on the second replicate and vice versa where a modest AUC of 0.63 and 0.64
was observed. Combining the features from the two batches, the classifier reached an AUC of 0.65
in test set performance (Figure 1—figure supplement 1A, Figure 1—figure supplement 2). Next,
the classifier was trained with additional features collected in a centriole siRNA screen, which was
a whole-genome siRNA study, was designed to identify regulators of centriole biogenesis and
provide background on cilia, flagella, and centrosome formation (Balestra et al., 2013). Centriole
data were downloaded from http://centriolescreen.vital-it.ch, to aggregate the effects of multiple
siRNA, we use the weighted median method as in the ATARiS approach (Shao et al., 2013), which
improved the AUC to 0.70 (Figure 1—figure supplement 1B, Figure 1—figure supplement 2).
Subsequently, the GTExs (GTEx Consortium, 2013) data, which enables evaluation between
genetic variation and gene expression in post-mortem human tissues, were used. We excluded
80 samples with low-RNA quality scores (RIN < 0.6), leaving 2,788 RNAseq samples from 52 tissues
for further analysis. Reads per kilobase per million (RPKM) scores are quantile normalized across all
samples. Next, for each tissue separately, we calculate the median expression RPKM score and
principle component gene loading values for a set of leading principle components chosen to
capture 95% of the total variance in each tissue (2–7 principle component, median 4 per tissue).
By including these expression features derived from the GTEx RNAseq data in the classifier, an
improvement to an AUC of 0.86 was reached (Figure 1—figure supplement 1C, Figure 1—figure
supplement 2).
Classification was performed using the Random Forest approach (Breiman, 2001); trees were
grown from bootstrapped samples of genes selected with replacement such that the number of
negative samples matches the number of positive ones (randomized under sampling) (Seiffert et al.,
2010). In each iteration, the square root the number of features was used (mtry, as suggested by
Brieman et al.). Each forest is comprised of 5,000 trees trained as above (ntree). All predicted scores
reported throughout our analysis are based on out-of-bag prediction scores (i.e., Random-Forest
cross-validation scores).
Gene set functional annotation clustering with DAVID
Functional annotation clustering of the CILIOGENESIS data set was performed with the online web
tool DAVID (Huang da et al., 2009b). A set of 591 high scoring genes from the final joined classifier
are used for the analysis (FDR < 0.1). CILIOGENESIS was tested for enrichment of GO FAT, KEGG,
and Reactome pathway categories using the medium stringency setting of DAVID. As a background
set, we use all genes, which have a full feature sets in all three data sources (16,810 genes;
Supplementary file 3C).
Gene set enrichment analysis with MsigDB
Gene set enrichment was performed by comparison against a collection of gene sets selected from
the MsigDB (v5.0) database (Hallmark set, GO set, KEGG set, and Reactome set) (Subramanian et al.,
2005). As a background set, we used all genes, which have a full feature sets in all three data sources
(16,431). Sets larger than 400 or smaller than 5 were excluded, and only sets with a minimal overlap of
three genes were included from the tested list in the p-value calculation. Enrichment p-value was
calculated using a hypergeometric test of enrichment, and are only sets with FDR <0.1 are reported
(estimated with B&H procedure).
Jonckheere–Terpstra test of trend
When considering any type of evidence, the trend is tested for each individual bin (0, 1, 2, 3, 4, 5, 6,
7, >8). For ‘human only’ evidence, the trend was tested for bins of (0, 1, 2, 3, >4) (Bewick et al., 2004).
Roosing et al. eLife 2015;4:e06602. DOI: 10.7554/eLife.06602 13 of 19
Research article Developmental biology and stem cells | Human biology and medicine
Genetic analysis
Patient Recruitment
Families were recruited for study based upon the presentation of JS in at least one member of the
family. This study was approved by the institutional review boards of the participating centers.
All subjects provided written informed consent (including consent to publish) prior to participation in
the study. Sampling of blood for this study was performed on the proband and all affected and
unaffected available genetically informative siblings and parents consistent with IRB guidelines or for
skin biopsies from the proband and one parent when available. All patients were evaluated directly by
one of the co-authors with specialty training in neurology, child neurology and/or clinical genetics, and
in accordance with local medical practices. Detailed pedigree information, symptomatology, detailed
general and neurological evaluations, brain/spine imaging and electrodiagnostic workup were
performed in all affected members as well as clinically suspected members of each family, along with
videos documenting the neurological examination in most cases.
Exome sequencing
We performed WES in 145 families with affected(s) displaying features consistent with JS. Blood was
acquired from informed, consenting individuals according to institutional guidelines, and DNA
extracted using established protocols. In solution, exome capture was performed using the SureSelect
Human All Exome 50 Mb Kit (Agilent Technologies, Santa Clara, CA) with 150-bp paired-end read
sequences generated on a HiSeq2000 (Illumina, San Diego, CA). Sequences were aligned to hg19 and
variants identified through the GATK pipeline (DePristo et al., 2011). Variations were annotated with
in-house software and the SeattleSeq server (Dixon-Salazar et al., 2012).
Systematic whole exome data analysis and variant identification
Initially, we systematically filtered for segregating (when WES of family member was present) autosomal
variants with a total allele frequency <1% in Exome Variant Server (EVS; version ESP6500SIV2).
Furthermore, all variants (except frame shifts variants) had a combined annotation dependent
depletion_phred score ≥10 (CADD) (Kircher et al., 2014). All possible single nucleotide variants CADD
scores were downloaded and provide a score to prioritize functional, deleterious and pathogenic variants
across many functional categories, effect sizes and genetic architectures was unmatched by any current
single-annotation method. Frameshift variants were included with a GERP-score ≥4.0 (Cooper et al.,
2005). Homozygous variants were filtered out when present in unaffected individuals from our in-house
database (n = 1,081), and compound heterozygous variants were removed when both were present in
unaffected individuals. After performance of this script, we focused on the gene set of 591 genes of FDR
<0.1 by applying a filter on the previous analysis. Variants in KIAA0586 were analyzed for pathogenesis
on the six largest transcripts (Supplementary file 4B) and segregation with disease within family members
by regular PCR reaction. Primers for variant analysis and whole-gene scanning were designed using
Primer3 (http://biotools.umassmed.edu/bioapps/primer3_www.cgi) (Supplementary file 5A).
mRNA and gDNA analysis by RT-PCR
Quantitative PCR on genomic DNA was performed to confirm a the large deletion of unknown specific
boundaries in MTI-1944. By analyzing two primer sets outside the deletion spanning exon 12 to 20
and two primer sets within the deletion quantity of PCR product was analyzed. Quantitative PCRs
were performed using the C1000 Touch Thermocycler (Bio-Rad, Hercules, CA) in 96 micro-well plates.
All samples were run in triplicate using iTaq Universal SYBR Green Supermix (Bio-Rad, Hercules, CA)
mastermix, exonic primers (Supplementary file 5B) and template DNA. Input of genomic DNA was
normalized against internal control gene GAPDH.
Total RNA was isolated from cultured fibroblasts from affected individual MTI-233-2-1 and MTI-103-
2-2 and unaffected MTI-233-1-2 and MTI-103-1-2 according to manufacturer’s protocol (Invitrogen,
Carlsbad, CA). Reverse transcription with SuperScript III First-Strand Synthesis System (Invitrogen,
Carlsbad, CA) was performed on 1 μg of total RNA. RT-PCR experiments were performed using 2.5 μl
cDNAwith primers in exons 8 and 10 (M2) and 10 and 12/13 (M3; intron spanning) (Supplementary file 5B)
(35 cycles) followed by Sanger sequencing using a 3730 ABI DNA Analyzer.
RNAi
Synthetic siRNA oligonucleotides were obtained fromDharmacon. Transfection of siRNAs using Lipofectamine
2000 or Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA) was performed according to the manufacturer’s
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instructions. The 21-nucleotide siRNA sequence for the non-specific control was 5′-AATTCTCCGAACGTGT
CACGT-3′. The 21-nucleotide siRNA sequence for human Talpid3 is 5′-CAAAGTTACCTACGTGTTATT-3′.
Western blotting
Fibroblasts were grown in DMEM supplemented with 10% FBS, grown to confluence, and subsequently
serum starved for 72 hr to induce cilium growth. Cells were lysed with ELB buffer (50 mM Hepes pH 7,
150 mM NaCl, 5 mM Ethylenediaminetetraacetic acid (EDTA)/pH 8, 0.1% NP-40, 1 mM Dithiothreitol
(DTT) DTT, 0.5 mM 4- benzenesulfonyl fluoride hydrochloride (AEBSF), 2 μg/ml leupeptin, 2 μg/ml
aprotinin, 10 mM NaF, 50 mM ß-glycerophosphate, and 10% glycerol) at 4˚C for 30 min. 100 μg of
lysate per sample in sample buffer was loaded on SDS-PAGE gels. Proteins were transferred to
a polyvinylidene difluoride (PVDF) membrane (GE Healthcare, Little Chalfont, UK) and blocked in 3%
non-fat milk in Phosphate-buffered saline (PBS). Rabbit polyclonal antibody against Talpid3 (dilution 1:
1,000) (Kobayashi et al., 2014) and a mouse monoclonal antibody against α-tubulin (Sigma–Aldrich,
dilution 1:5,000) were incubated overnight at 4˚C.
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predicted ciliary genes and non-ciliary genes. (B) The CILIOGENESIS data set containing the genes
predicted by the classifier to be ciliary. (A–B) Genes predicted by the classifier to be ciliary are color
coded. Green rows represents the genes with an FDR <0.01, yellow with FDR <0.1, orange with FDR
<0.2, and the remainder (until FDR <0.267) is colored in dark orange. (C) Enrichment analysis by
performing enrichment analysis with DAVID on the CILIOGENESIS database (excluding SCGCv1
genes). (D) Enrichment analysis with MsigDB (v4.0, gene sets from GO, KEGG and Reactome) on the
CILIOGENESIS database (excluding SCGCv1 genes). (E) Enrichment analysis by performing
enrichment analysis with MsigDB on the genes with FDR <0.01 within the CILIOGENESIS database
(excluding SCGCv1 genes). (F) Enrichment analysis of hypergeometric gene set on MsigDB onto the
true positive genes (SCGCv1 genes ranked within the CILIOGENESIS data set genes). (G) Gene set
enrichment on MsigDB onto false negative genes (SCGCv1 genes ranked outside the CILIOGENESIS
data set genes).
DOI: 10.7554/eLife.06602.017
· Supplementary file 4. Clinical features and KIAA0586 mutations. (A) Clinical features of individuals
with KIAA0586 mutations. (B) Nomenclature per isoform of the identified KIAA0586 mutations.
DOI: 10.7554/eLife.06602.018
· Supplementary file 5. Primers. (A) Primers for KIAA0586 mutation confirmation and segregation
analysis. (B) Primers for KIAA0586 mRNA and expression analysis.
DOI: 10.7554/eLife.06602.019
Major datasets
The following previously published datasets were used:
Author(s) Year Dataset title
Dataset ID
and/or URL
Database, license, and
accessibility information
van Dam TJ, Wheway G,
Slaats GG, SYSCILIA
Study Group, Huynen
MA, Giles RH
2013 The SYSCILIA gold
standard (SCGSv1)
http://www.syscilia.org/
goldstandard.shtml
Publicly available at
SYSCILIA (Accession no:
23725226).
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Author(s) Year Dataset title
Dataset ID
and/or URL
Database, license, and
accessibility information
Wishart DS, Jewison T,
Guo AC, Wilson M, Knox
C, Liu Y, Djoumbou Y,
Mandal R, Aziat F, Dong
E, Bouatra S, Sinelnikov I,
Arndt D, Xia J, Liu P,
Yallou F, Bjorndahl T,
Perez-Pineiro R, Eisner R,
Allen F, Neveu V, Greiner
R, Scalbert A
2013 HMDB 3.0–The Human
Metabolome Database
www.hmdb.ca Publicly available at
Human Metabolome
Database (Accession no:
23161693).
Balestra FR, Strnad P,
Flu¨ckiger I, Go¨nczy P
2013 Centriole screen http://centriolescreen.
vital-it.ch
Publicly available at
Centiole Screen
(Accession no: 23769972).
Consortium 2013 The Genotype-Tissue
Expression (GTEx) project
http://www.gtexportal.
org/home/
Publicly available at
Genotype-Tissue
Expression (Accession no:
23715323).
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